Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06375460 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Real-time Engagement for Learning to Effectively Control Type 2 Diabetes

Study acronym: REFLECT2D
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Primary endpoints: details revised at 1 of 16 entries · Start date changed from estimate of Sep 30, 2026 to Sep 20, 2026 · Eligibility criteria expanded, about 6 words · 2 more Show 5 more changesShow less
    • Primary endpoints: details revised at 1 of 16 entries
    • Start date changed from estimate of Sep 30, 2026 to Sep 20, 2026
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site details revised
  2. Interventions modified Trial arms changed: 4 → 3 · Eligibility criteria shortened, about 16 words · Study description shortened, about 92 words · 1 morev10 Show 4 more changesShow less
    • Trial arms changed: 4 → 3
    • Eligibility criteria shortened, about 16 words
    • Study description shortened, about 92 words
    • Study site revised

    See this version in full on ClinicalTrials.gov ↗

  3. Start date: Jul 2026 to Sep 30, 2026v9
  4. Primary completion date: Apr 2028 to Jul 2029 Start date: Apr 2026 to Jul 2026 · Completion date: Sep 2029 to Aug 2029v8 Show 2 more changesShow less
    • Start date: Apr 2026 to Jul 2026
    • Completion date: Sep 2029 to Aug 2029
  5. Start date: Sep 2025 to Apr 2026 Primary completion date: Sep 2028 to Apr 2028v7 Show 1 more changeShow less
    • Primary completion date: Sep 2028 to Apr 2028
Show 5 earlier versionsHide 5 earlier versions
  1. Start date: Jul 2025 to Sep 2025 Primary completion date: Jun 1, 2028 to Sep 2028 · Completion date: Jun 30, 2029 to Sep 2029 · Interventions: Focused App Prompt (Behavioral), No App Prompt (Behavioral) to Focused App Prompt (Behavioral), No App Prompt (Behavioral), Outreach for Missing Data (Behavioral) · 5 morev6 Show 8 more changesShow less
    • Primary completion date: Jun 1, 2028 to Sep 2028
    • Completion date: Jun 30, 2029 to Sep 2029
    • Interventions: Focused App Prompt (Behavioral), No App Prompt (Behavioral) to Focused App Prompt (Behavioral), No App Prompt (Behavioral), Outreach for Missing Data (Behavioral)
    • Secondary endpoints: 3 to 2
    • Study description expanded, about 37 words
    • Collaborators: 4 to 5
    • Study arms: 3 to 4
    • Eligibility criteria shortened, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  2. Start date: May 2025 to Jul 2025v5
  3. Start date: Mar 2025 to May 2025v4
  4. Start date: Nov 2024 to Mar 2025v3
  5. Start date: Sep 1, 2024 to Nov 2024v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn if a new smartphone app that pairs glucose and exercise data will help adolescents and young adults with type 2 diabetes improve glycemic control. It will also study how changes in glycemic control are maintained over time. The main questions it aims to answer are: * Does using the app help with short-term glycemic control? * Does using the app help with longer-term glycemic control? * Does using the app help increase physical activity? Participants will: * Wear a continuous glucose monitoring device for 6 months * Wear a physical activity tracker for 6 months * Use the study smartphone app for 6 months * Complete 3 in-person study visits with fasting blood draws * Report dietary intake intermittently throughout the study
Trial Details
NCT Number NCT06375460
Lead Sponsor University of Pittsburgh
Collaborators: Dartmouth College, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Michigan, San Diego State University, Emory University
Conditions Diabetes Mellitus, Type 2, Lifestyle, Hyperglycemia, Physical Inactivity
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov